CW INNOVATION PROGRAMME EXPLORES DIGITAL MANAGEMENT OF HIV
22nd September 2021. Today, Chelsea and Westminster Hospital NHS Foundation Trust announces a new partnership with biopharmaceutical company, Gilead Sciences, as part of its flagship CW Innovation programme, which tests and scales technologies and innovations that improve patient care, patient experience and the way we run our hospitals.
The partnership with Gilead Sciences is one of a long line of collaborations between leading UK and international organisations and the CW Innovation programme, which is led jointly by Chelsea and Westminster Hospital NHS Foundation Trust and its charity CW+. The joint working project will initially involve a scoping exercise to assess the potential impact of digital technologies on patient outcomes as well as staff and patient time. It will also look to assess the ability of people living with HIV to self-care and the improvement in clinical knowledge for health care professionals in the management of people living with HIV with complex needs.
The announcement comes during the two-year anniversary celebrations of CW Innovation, which, catalysed by the COVID-19 pandemic, has fast-tracked transformative innovations across the Trust, harnessing digital healthcare, AI and machine learning to fundamentally change the way care is delivered to patients.
As more people are living with HIV than ever before, their health and care needs are becoming more complex as they age. This new partnership aims to enhance the lives of people living with HIV in ageing and/or with co-morbidities using digital technologies. Moreover, the project will analyse Chelsea and Westminster Hospital NHS Foundation Trust’s HIV patient service pathway for older adults and those with comorbidities and identify whether digital technologies could improve it.
Prof Marta Boffito, Consultant Physician and HIV Service Director and Clinical Research Facility Lead at Chelsea and Westminster Hospital NHS Foundation Trust, said: “Together with our charity CW+, we welcome the opportunity to collaborate with Gilead Sciences on this all-important research project, which will capture the patient voice and experience, providing us with clear insights on how we can improve the care of older adults living with HIV and those with comorbidities by further incorporating digital technology in our service”.
Chelsea and Westminster Hospital NHS Foundation Trust, which runs one of the largest HIV services in Europe and the largest in the UK, has been at the forefront of the global fight against HIV and AIDS for over 30 years, with its clinical teams pioneering the research, innovation and care of people living with HIV.
Find out more about CW Innovation here.